A team of authors from the University of Colorado demonstrated significantly elevated plasma levels of GDF-15 in patients with systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) compared to SSc patients without PAH. The gene discussed is GDF15; the disease is pulmonary arterial hypertension.